Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events

IntroductionImmunotherapies have improved the prognosis of many cancer patients including patients with advanced melanoma. Immune checkpoint receptors including CTLA-4 and PD-1 have been established as main therapeutic targets for immunotherapy of melanoma. Although monotherapy is effective in melan...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Benjamin Müller, Anne Bärenwaldt, Petra Herzig, Alfred Zippelius, Lara Valeska Maul, Viviane Hess, David König, Heinz Läubli
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2023-04-01
主題:	cancer immunotherapy PD-1 CTLA-4 immune checkpoint colitis hepatitis
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1125111/full